EcoDrugPlus

Leukotriene B4 Receptor 2b

Ensembl ID : ENSSMAG00000010340
Gene Symbol: LTB4R2B
3 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSSMAG00000019502
Gene Symbol: KDM1A
1 Cross references
212 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSSMAG00000008592
Gene Symbol: LOXL2A
3 Cross references
208 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSSMAG00000017593
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSSMAG00000019177
Gene Symbol: MIF
2 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor B

Ensembl ID : ENSSMAG00000014995
Gene Symbol: MST1RB
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSSMAG00000016930
Gene Symbol: LOC118309549
2 Cross references
188 Possible Orthologues:

Malignant Fibrous Histiocytoma Amplified Sequence 1

Ensembl ID : ENSSMAG00000008225
Gene Symbol: MFHAS1
2 Cross references
710 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSSMAG00000005945
Gene Symbol: MMP14A
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSSMAG00000014173
Gene Symbol: MMP14B
1 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSSMAG00000008836
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSSMAG00000019171
Gene Symbol: MMP9
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).